ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Oyavas 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung - 
67857002 Spirig HealthCare AG
Oyavas 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung04.06.2021
  04.06.2021
(L01FG01) 
WHO-DDD03.06.2026
07.16.10. 
07.16.10. 
A  
Yes 
IP 
962.84Yes
    
10 %1063.55
  
7680678570024Biotechnologika
  
Composition
bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.68 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Bevacizumab400mg / 16ml
BAG: Active AgentDose
Bevacizumab400 mg
 
Inactive agents
Disodium Phosphate
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home